based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts offering long term price targets for Aarti Drugs Ltd. An average target of ₹555
Source: S&P Global Market Intelligence
Aarti Drugs Ltd price forecast by 1 analysts
Upside of24.36%
High
₹555
Target
₹555.00
Low
₹555
Aarti Drugs Ltd target price ₹555, a slight upside of 24.36% compared to current price of ₹445.15. According to 1 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Aarti Drugs Ltd revenue growth forecast
Expected growth rate Q1, FY2026:13.48%
Forecast
Actual
Including amortisation and stock based compensations
Aarti Drugs Ltd EPS growth forecast
EPS estimate Q1, FY2026:44.77%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -4.51 % |
3 Month Return | -14.98 % |
1 Year Return | -7.35 % |
Market Stats | |
Previous Close | ₹446.30 |
Open | ₹446.30 |
Volume | 1.36L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹4,103.06Cr |
P/E Ratio | 26.9 |
PEG Ratio | -9.24 |
Market Cap | ₹4,103.06 Cr |
P/B Ratio | 3.39 |
EPS | 18.66 |
Dividend Yield | 0.23 |
Sector | Pharmaceuticals |
ROE | 12.39 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹4,103.06 Cr | 50.86% | 0.64 | ₹171 Cr | ₹2,528 Cr | |
HOLD | ₹32,491.40 Cr | 131.47% | 0.52 | ₹300 Cr | ₹1,051 Cr | |
BUY | ₹17,918.06 Cr | 29.23% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
NA | ₹6,984.68 Cr | 5.78% | 0.79 | -₹388 Cr | ₹75 Cr | |
BUY | ₹16,534.14 Cr | 52.33% | 0.68 | ₹218 Cr | ₹1,296 Cr |
Organisation | Aarti Drugs Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Aarti Drugs Ltd
Aarti Drugs Gains GMP Certification, Shares Rise - 04 Oct, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
Mutual Funds have increased holdings from 5.70% to 6.25% in Sep 2024 quarter
Revenue Rich
Revenue is up for the last 2 quarters, 556.45 Cr → 599.81 Cr (in ₹), with an average increase of 7.2% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, 33.24 Cr → 35.01 Cr (in ₹), with an average increase of 5.1% per quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 62.8% return, outperforming this stock by 70.1%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 34.02% of holdings in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 136.8% return, outperforming this stock by 159.9%
FII Holding Down
Foreign Institutions have decreased holdings from 2.96% to 2.50% in Sep 2024 quarter
Promoter Holding Down
Promoters have decreased holdings from 55.67% to 55.64% in Sep 2024 quarter
Price Dip
In the last 1 month, AARTIDRUGS stock has moved down by -4.5%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 55.64% | ||
Foreign Institutions | 2.5% | ||
Mutual Funds | 6.25% | 9.64 | |
Retail Investors | 34.02% | 0.00 | |
Others | 1.58% |
Aarti Drugs Ltd in the last 5 years
Lowest (8.29x)
March 31, 2020
Today (26.90x)
December 12, 2024
Industry (56.92x)
December 12, 2024
Highest (57.24x)
August 24, 2020
Aarti Drugs Ltd’s net profit fell -11.57% since last year same period to ₹35.01Cr in the Q2 2024-2025. On a quarterly growth basis, Aarti Drugs Ltd has generated 5.32% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending December 2023, Aarti Drugs Ltd has declared dividend of ₹1 - translating a dividend yield of 0.45%.
Read More about DividendsBearish
Neutral
Bullish
Aarti Drugs Ltd is currently in a Bearish trading position according to technical analysis indicators.
Aarti Drugs Ltd (AARTIDRUGS) share price today is ₹445.15
Aarti Drugs Ltd is listed on NSE
Aarti Drugs Ltd is listed on BSE
PE Ratio of Aarti Drugs Ltd is 26.9
PE ratio = Aarti Drugs Ltd Market price per share / Aarti Drugs Ltd Earnings per share
Today’s traded volume of Aarti Drugs Ltd(AARTIDRUGS) is 1.36L.
Today’s market capitalisation of Aarti Drugs Ltd(AARTIDRUGS) is ₹4103.06Cr.
Aarti Drugs Ltd(AARTIDRUGS | Price |
---|---|
52 Week High | ₹635 |
52 Week Low | ₹431.05 |
Aarti Drugs Ltd(AARTIDRUGS) share price is ₹445.15. It is down -29.90% from its 52 Week High price of ₹635
Aarti Drugs Ltd(AARTIDRUGS) share price is ₹445.15. It is up 3.27% from its 52 Week Low price of ₹431.05
Aarti Drugs Ltd(AARTIDRUGS | Returns |
---|---|
1 Day Returns | -1.15% |
1 Month Returns | -4.51% |
3 Month Returns | -14.98% |
1 Year Returns | -7.35% |